Clinical and genetic correlates of circulating angiopoietin-2 and soluble tie-2 in the community

Wolfgang Lieb, Justin P. Zachariah, Vanessa Xanthakis, Radwan Safa, Ming Huei Chen, Lisa M. Sullivan, Martin G. Larson, Holly M. Smith, Qiong Yang, Gary F. Mitchell, Joseph A. Vita, Douglas B. Sawyer, Ramachandran S. Vasan

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Background-Experimental studies suggest that endothelial growth factors play an important role in angiogenesis and vascular remodeling. The clinical and genetic correlates of circulating angiopoietin-2 (Ang-2) and its soluble receptor/regulator Tie-2 (sTie-2) have not been determined in a community-based sample. Methods and Results-Serum Ang-2 and sTie-2 were assayed in 3778 third-generation cohort participants of the Framingham Heart Study (mean age, 40±9 years; 53% women). Clinical correlates and heritability of both biomarkers were assessed using generalized estimating equations and variance-component analyses. Ang-2 levels were higher and sTie-2 levels were lower in women than in men. Ang-2 was positively related to age, smoking, systolic blood pressure, hypertension treatment, and diabetes (P<0.05 for all) but was inversely associated with total cholesterol and diastolic blood pressure (P<0.0001 for both), and sTie-2 was positively associated with body mass index, diabetes, and triglycerides but was inversely related to age, alcohol consumption, and glomerular filtration rate (P<0.05 for all). Both Ang-2 and sTie-2 were higher in participants with metabolic syndrome (P<0.005), with stronger associations of Ang-2 with blood pressure traits and of sTie-2 with obesity-dyslipidemia components. Heritability estimates for Ang-2 and sTie-2 were 27% and 56%, respectively (P<0.0001). A region on chromosome 9 was significantly linked to circulating sTie-2 levels (logarithm of the odds score, 8.31). Conclusion-Circulating levels of Ang-2 and sTie-2 are heritable traits associated with cardiovascular disease risk factors, including the metabolic syndrome. These observations are consistent with the notion that angiogenesis and vascular remodeling are determined in part by genetic influences and associated with metabolic risk factors.

Original languageEnglish (US)
Pages (from-to)300-306
Number of pages7
JournalCirculation: Cardiovascular Genetics
Volume3
Issue number3
DOIs
StatePublished - Jun 2010
Externally publishedYes

Keywords

  • Angiopoietins
  • CVD risk factors
  • Epidemiology
  • Growth substances
  • Heritability
  • Metabolic syndrome
  • Vascular remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)
  • Genetics

Fingerprint

Dive into the research topics of 'Clinical and genetic correlates of circulating angiopoietin-2 and soluble tie-2 in the community'. Together they form a unique fingerprint.

Cite this